Seth Harmon

Directeur Financier/CFO chez VIRIDIAN THERAPEUTICS, INC.

Fortune : 12 700 $ au 30/04/2024

45 ans

Health Technology

Consumer Services

Postes actifs de Seth Harmon

Sociétés	Poste	Début	Fin
VIRIDIAN THERAPEUTICS, INC.	Comptroller/Controller/Auditor	12/09/2023	-
	Directeur Financier/CFO	12/09/2023	-
	Corporate Officer/Principal	01/05/2023	12/09/2023

Sociétés	Poste	Début	Fin
BIONTECH SE	Directeur Financier/CFO	01/05/2020	01/05/2023
NEON THERAPEUTICS, INC.	Corporate Officer/Principal	01/04/2017	01/05/2020

Northeastern University	Graduate Degree
Bowdoin College	Undergraduate Degree

Internationale

Etats-Unis	5
Allemagne	2

Opérationnelle

Director of Finance/CFO	2
Corporate Officer/Principal	2
Comptroller/Controller/Auditor	1

Sectorielle

Health Technology	4
Consumer Services	3

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	2
VIRIDIAN THERAPEUTICS, INC.	Health Technology
BIONTECH SE	Health Technology

Entreprise privées	1
BioNTech US, Inc. BioNTech US, Inc. BiotechnologyHealth Technology BioNTech US, Inc. develops novel therapeutics leveraging neoantigen biology to treat cancer. It offers NEO-PV-01, a personalized neoantigen vaccine that builds upon initial clinical trials. The company was founded by James P. Allison, Edward J. Fritsch, Nir Hacohen, Eric S. Lander, Robert Schreiber, Ton Schumacher and Catherine Wu on October 21, 2013 and is headquartered in Cambridge, MA.	Health Technology

Entreprise privées

Health Technology